TRT Baseline Bloodwork

A 36-biomarker panel designed as a pre-treatment baseline for men considering or beginning testosterone replacement therapy. Measures testosterone markers alongside comprehensive health indicators to establish starting values that TRT progress can be measured against.

The TRT Baseline Bloodwork panel is specifically structured for men at the start of their testosterone replacement journey. Before beginning TRT, establishing comprehensive baseline measurements is critical — both for tracking the efficacy of treatment and for monitoring potential side effects on liver, kidney, cardiovascular, and haematological health. The panel goes beyond simple testosterone measurement to include the full androgenic axis (total and free testosterone, SHBG, oestradiol, LH, FSH), which helps distinguish between primary hypogonadism (testicular) and secondary hypogonadism (pituitary). This distinction matters because it affects treatment approach and monitoring requirements. Health markers cover the organ systems most commonly monitored during TRT — liver function (testosterone is hepatically metabolised), haematology (testosterone stimulates erythropoiesis, potentially raising haematocrit to dangerous levels), lipids (TRT can affect cholesterol ratios), and kidney function. This panel provides the comprehensive pre-treatment dataset that responsible TRT prescribers require, and creates the baseline against which future monitoring panels can be compared to ensure treatment is both effective and safe.